Clinical Trials
21 trialsNCT07440290 2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3 Not yet recruiting
NCT07319897 2026-01-06
A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.
Peking University First Hospital
Phase 2/3 Not yet recruiting
NCT05768178 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT04513639 2025-03-20
The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study
Oslo University Hospital
Phase 2/3 Recruiting
NCT06879379 2025-03-17
KPD Consolidation After ASCT in NDMM Patients
Peking University People's Hospital
Phase 2/3 Recruiting
NCT03428373 2024-02-29
RithMM
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2/3 Unknown
NCT03759093 2023-09-06
CURATE.AI Optimized Modulation for Multiple Myeloma
National University Hospital, Singapore
Phase 2/3 Unknown
NCT00177047 2021-11-09
Autologous Transplant for Multiple Myeloma
Masonic Cancer Center, University of Minnesota
Phase 2/3 Completed
NCT03385096 2020-02-25
Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown
NCT02145598 2019-01-16
GERMAIN
University of Jena
Phase 2/3 Terminated
NCT00038090 2018-10-31
Thalidomide-Dexamethasone for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2/3 Completed
NCT02419118 2017-11-07
DARA
Vejle Hospital
Phase 2/3 Completed
NCT00714259 2017-07-24
Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
University of Alabama at Birmingham
Phase 2/3 Terminated
NCT00984828 2016-09-08
Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Terminated
NCT00861250 2016-06-17
Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT
Tampere University Hospital
Phase 2/3 Completed
NCT00205751 2013-11-25
Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy
Austrian Forum Against Cancer
Phase 2/3 Completed
NCT00090493 2013-06-24
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
University of Arkansas
Phase 2/3 Completed
NCT00998270 2012-06-04
Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma
Tehran University of Medical Sciences
Phase 2/3 Unknown
NCT01085058 2010-03-11
CU01
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 2/3 Completed
NCT00415987 2008-06-20
Hematopoietic Stem Cell Transplantation in Myeloma
Azienda Ospedaliera San Giovanni Battista
Phase 2/3 Unknown
NCT00300664 2006-10-13
A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.
Royal Marsden NHS Foundation Trust
Phase 2/3 Completed